The Neuromyelitis Optica Spectrum Disorder Financial Assistance Program at The Assistance Fund

Struggling with out-of-pocket expenses due to neuromyelitis optica spectrum disorder? The Assistance Fund (TAF) helps patients and families facing high medical out-of-pocket costs by providing financial assistance for copayments, coinsurance, deductibles, and other health-related expenses. Since its founding in 2009, TAF has helped nearly 135,000 children and adults in all 50 states, Washington, DC, and Puerto Rico.

Among TAF’s more than 70 disease programs is the Neuromyelitis Optica Spectrum Disorder Financial Assistance Program. The Neuromyelitis Optica Spectrum Disorder Financial Assistance Program provides financial assistance for out-of-pocket costs associated with prescription drug assistance (copays, deductibles, and coinsurance) on FDA-approved treatment, health insurance premiums, therapy administration costs, disease management (such as prescribing physician copayments), treatment-related travel costs, and diagnostic laboratory tests.

To be eligible for assistance, patients must be U.S. citizens or permanent residents, meet certain income requirements, have a diagnosis of the disease named in the disease program, have government or private health insurance, and a prescription for an FDA-approved treatment for the disease. Once a patient is enrolled in a disease program, their coverage lasts the entire calendar year and there is no cap on the amount of assistance in that calendar year.

To learn more, or to apply today, visit:, or call (855) 803-6515.